SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 14.38
+0.38 (2.68%)
Aug 15, 2025, 4:35 PM GMT+1
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 37.20 million as of August 15, 2025. Its market cap has increased by 19.66% in one year.
Market Cap
37.20M
Enterprise Value
36.99M
Revenue
2.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.38
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 37.20M, an increase of 136.50%. That is a compound annual growth rate of 10.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.66B |
| GSK plc | 56.72B |
| Haleon | 32.11B |
| Smith & Nephew | 11.81B |
| ConvaTec Group | 4.73B |
| Hikma Pharmaceuticals | 3.96B |
| Oxford Nanopore Technologies | 2.04B |
| HUTCHMED (China) | 2.01B |